WHO: AstraZeneca vaccine should be used despite virus variants

WHO vaccine experts say the AstraZeneca-Oxford COVID-19 vaccine could be used for people over the age of 65, and also in settings where variants of the virus are circulating.

“Taking the totality of available evidence into account, WHO recommends the vaccine for use in persons aged 65 years and older,” The 15-member Strategic Advisory Group of Experts on Immunization (SAGE) says in fresh recommendations.

It says the vaccine could also be used in places where “variants are present,” despite a recent study suggesting it was far less effective against a strain of the virus first detected in South Africa.

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.